No black box warning on record for Nevirapine

As of the latest FDA labeling reviewed, Nevirapine (NEVIRAPINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Nevirapine medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Monitor patients for immune reconstitution syndrome and fat redistribution. ( 5.5 , 5.6 ) 5.1 Hepatotoxicity and Hepatic Impairment Severe, life-threatening, and in some cases fatal hepatotoxicity, including fulminant and cholestatic hepatitis, hepatic necrosis and hepatic failure, have been reported in patients treated with nevirapine. The risk of symptomatic hepatic

No black box warning on record for Nevirapine

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Monitor patients for immune reconstitution syndrome and fat redistribution. ( 5.5 , 5.6 ) 5.1 Hepatotoxicity and Hepatic Impairment Severe, life-threatening, and in some cases fatal hepatotoxicity, including fulminant and cholestatic hepatitis, hepatic necrosis and hepatic failure, have been reported in patients treated with nevirapine. The risk of symptomatic hepatic

Nevirapine Black Box Warning

No black box warning on record for Nevirapine

Other warnings & precautions

Nevirapine Black Box Warning

No black box warning on record for Nevirapine

Other warnings & precautions